Paul G. Allen

Chembio lands $550K grant for Zika test

Chembio Diagnostics has been awarded a $550,000 “catalyst grant” to develop a rapid test for the Zika virus and similar maladies. The grant comes from Microsoft co-founder Paul G. Allen, who has a long history of supporting Chembio’s research efforts, most recently surrounding the Ebola outbreak. Company officials said Chembio will develop a test to detect Zika alone, and another to detect Zika, dengue and chikungunya viruses. The company also will add Zika to a six-virus…